Sessa C - Search Results

1

Adjuvant therapy for colon cancer: present and perspectives.

De Dosso S, Sessa C, Saletti P. De Dosso S, et al. Among authors: sessa c. Cancer Treat Rev. 2009 Apr;35(2):160-6. doi: 10.1016/j.ctrv.2008.10.001. Epub 2008 Nov 13. Cancer Treat Rev. 2009. PMID: 19013023 Review.

2

A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas.

Fiedler W, DeDosso S, Cresta S, Weidmann J, Tessari A, Salzberg M, Dietrich B, Baumeister H, Goletz S, Gianni L, Sessa C. Fiedler W, et al. Among authors: sessa c. Eur J Cancer. 2016 Aug;63:55-63. doi: 10.1016/j.ejca.2016.05.003. Epub 2016 Jun 7. Eur J Cancer. 2016. PMID: 27285281 Free article. Clinical Trial.

3

Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores.

Broekman KE, Jalving M, van Tinteren H, Sessa C, Reyners AKL. Broekman KE, et al. Among authors: sessa c. Cancer Treat Rev. 2018 Sep;69:233-242. doi: 10.1016/j.ctrv.2018.06.008. Epub 2018 Jun 18. Cancer Treat Rev. 2018. PMID: 30098485 Free article. Review.

4

Two cases of neurotoxicity possibly related to 5-fluorouracil and FA administration.

Saletti P, Pagani O, Sessa C, Goldhirsch A. Saletti P, et al. Among authors: sessa c. Ann Oncol. 1996 Feb;7(2):213-4. doi: 10.1093/oxfordjournals.annonc.a010554. Ann Oncol. 1996. PMID: 8777183 No abstract available.

5

Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.

Sessa C, Colombo N, Bolis G, Marsoni S, Mangioni C. Sessa C, et al. Cancer Treat Rev. 1991 Mar;18 Suppl A:37-46. doi: 10.1016/0305-7372(91)90023-s. Cancer Treat Rev. 1991. PMID: 1904308 Clinical Trial. No abstract available.

6

Update on PARP1 inhibitors in ovarian cancer.

Sessa C. Sessa C. Ann Oncol. 2011 Dec;22 Suppl 8:viii72-viii76. doi: 10.1093/annonc/mdr528. Ann Oncol. 2011. PMID: 22180407 Free article.

7

Randomized single-agents trials in recurrent epithelial ovarian cancer.

Sessa C, Marsoni S. Sessa C, et al. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:247-51. doi: 10.1111/j.1525-1438.2005.00437.x. Int J Gynecol Cancer. 2005. PMID: 16343240 Free article. Review.

8

Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy.

Goldhirsch A, Greiner R, Dreher E, Sessa C, Krauer F, Forni M, Jungi FW, Brunner KW, Veraguth P, Engeler V, et al. Goldhirsch A, et al. Among authors: sessa c. Cancer. 1988 Jul 1;62(1):40-7. doi: 10.1002/1097-0142(19880701)62:1<40::aid-cncr2820620110>3.0.co;2-o. Cancer. 1988. PMID: 3133102 Clinical Trial.

9

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.

Thürlimann B, Price KN, Gelber RD, Holmberg SB, Crivellari D, Colleoni M, Collins J, Forbes JF, Castiglione-Gertsch M, Coates AS, Goldhirsch A; International Breast Cancer Study Group. Thürlimann B, et al. Breast Cancer Res Treat. 2009 Jan;113(1):137-44. doi: 10.1007/s10549-008-9912-9. Epub 2008 Feb 8. Breast Cancer Res Treat. 2009. PMID: 18259856 Free PMC article. Clinical Trial.

10

Docetaxel and epirubicin in advanced breast cancer.

Sessa C, Pagani O. Sessa C, et al. Oncologist. 2001;6 Suppl 3:13-6. doi: 10.1634/theoncologist.6-suppl_3-13. Oncologist. 2001. PMID: 11346679 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters